Data Collection Using Eko Digital Devices in a Clinical Setting
Condition(s) studied
Investigational drug(s) / intervention(s)
Eko digital stethoscopes: Use of the Eko CORE 500 digital stethoscope and 3M Littmann CORE Digital Stethoscope to listen for and record lung sounds.
Study summary
The purpose of this research is to prospectively train and validate an artificial intelligence machine learning (ML) algorithm to detect the presence of adventitious lung sounds in adults. Clinicians will use the Eko CORE and/or Eko CORE 500 device(s) in real clinical settings to collect normal and abnormal lung sounds, as part of standard of care clinical practice, which will then be used to explore an ML algorithm for classifiers for wheeze, coarse crackle, fine crackle, rhonchus, stridor, rales, and cough, as well as determine any correspondences between the type and/or location of adventitious lung sounds and the type of pulmonary conditions as reported by clinicians.
Eligibility
Primary outcome measure(s)
- Primary Objective — Through study completion, an average of 8-9 months
The primary objective of this study is to collect normal and abnormal lung sounds of up to 750 patients per study site, by having clinicians use the Eko CORE and/or Eko CORE 500 device(s) in real clinical settings, as part of standard of care clinical practice which will then be used to explore an ML algorithm for classifiers for wheeze, coarse crackle, fine crackle, rhonchus, stridor, rales, and cough, as well as determine any correspondences between the type and/or location of adventitious lung sounds and the type of pulmonary conditions as reported by clinicians.
Trial sites (2)
| Facility | City | Region | Status |
|---|---|---|---|
| Nemours Children's Health | Jacksonville | Florida | Recruiting |
| Jefferson Einstein Philadelphia Hospital | Philadelphia | Pennsylvania | Recruiting |
More Eko Devices, Inc. trials in the USA
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07227376 on ClinicalTrials.gov ↗ ← All trials in the USA